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Introduction   
   
In an extensive review by Sherman et al of 257 patients in 1984(1), it was found that a 
particular form of leukoplakia emerged which was very aggressive but initially 
presented as a hyperkeratosis. Hansen et al in 1985(2) 
 
proposed that this lesion 
should be called Proliferative Verrucous Leukoplakia (PVL). This group of lesions 
designated as PVL encompasses a spectrum of clinical and histopathological stages. 
These lesions exhibit a high recurrence rate and at times the clinical and microscopic 
features of malignancy. We present a case of PVL which not only recurred but also 
rapidly progressed histologically from a mild dysplasia to verrucous carcinoma in a 
span of eight months after its initial excision. We discuss some of the salient features 
of this unusual lesion. 
Case Description 
             A 58 year old edentulous female patient reported with multifocal white 
patches in the oral cavity predominantly on both the alveolar ridges bilaterally. A 
solitary thick homogenous leukoplakia was present on the left maxillary alveolar ridge 
in the molar region and thin leukoplakic patches on the rest of the maxillary alveolar 
ridge and also bilaterally on the mandibular alveolar ridge (Fig. 1a & 1b). At the time 
of presentation she didn’t have the habit of tobacco consumption in any form. She 
gave a history of minimal tobacco usage for a  duration of about a year, 8-10 years 
back.  
           Excisional biopsy of the thick leukoplakic patch on the left posterior maxillary 
alveolar ridge revealed hyperkeratosis with mild dysplasia (Fig. 2). 
          The patient was lost to follow up and reported after 8 months, wherein it was 
observed that the lesion had recurred as a diffuse verrucous white lesion extending on 
to the adjacent buccal sulcus  and an erythematous patch on the hard palate (Fig. 3). 
OPG revealed bony erosion of the left maxillary alveolus (Fig. 4). 
        Deep excisional biopsy (Fig. 5) of the left verrucous white area on the maxillary 
alveolus with adjoining erythematous red patch revealed features of verrucous 
carcinoma with a blunt invasive front, cytologically banal appearance and 
parakeratotic plugging. Biopsy also showed extensive hyperkeratosis, keratin 
projections and broad bulbous rete ridges exhibiting an endophytic downward growth 
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Abstract      
                         
  Aims and Objectives: To alert the clinician about this seemingly innocuous lesion which has a 
spectrum of clinical and histopathological stages and a malignant transformation rate of 100%.   
Case description: We present a case of Proliferative Verrucous Leukoplakia (PVL) of a 58 year 
old female patient which progressed to carcinoma despite therapy. 
Discussion: PVL is a unique type of oral leukoplakia which has an enigmatic etiology, aggressive 
behavior, high recurrence rate, with relentless progression and is refractory to therapy. Unlike 
other types of leukoplakia, it is minimally associated with the use of tobacco.  
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Fig. 1(b)-  Initial presentation- Thick homogenous leukoplakia on 
left posterior maxillary alveolus. Rest of the alveolar ridge shows 
extensive involvement as thin homogenous leukoplakia. 
 
Fig. 2-  Histopathological appearance of homogenous 
leukoplakic patch at initial presentation 
 
Fig. 1(a)-Initial presentation- Linear leukoplakic patch on 
mandibular alveolar ridge bilaterally. 
 
Fig. 4- Later presentation- OPG shows erosion of bone of the left 
maxillary alveolus from canine onwards posteriorly. 
 
Fig. 3- Later presentation-The homogenous leukoplakia patch has 
turned verrucous & extended on the adjacent buccal mucosa and 
hard palate as erythematous patch. 
 
Fig. 5- Histopathology at later presentation - Epithelium has 
banal appearance. Endophytic proliferation of epithelium with 
parakeratin plugging. 
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carcinoma with a blunt invasive front, cytologically 
banal appearance and parakeratotic plugging. Biopsy 
also showed extensive hyperkeratosis, keratin 
projections and broad bulbous rete ridges exhibiting 
an endophytic downward growth pattern (Fig. 6, 7 & 
8). 
 
Discussion 
 
 Clinical features 
PVL may appear on any soft tissue surface of the oral 
cavity presenting as a single distinct lesion which 
usually has the clinical appearance of a solitary 
homogenous leukoplakia. This seemingly innocuous 
leukoplakic lesion recurs and insidiously spreads over 
time resulting in a diffuse, multifocal, exophytic or 
warty type of oral lesions(3). An erythematous 
component may sometimes be seen. The most 
common sites affected are the buccal mucosa and 
tongue while the palatal mucosa, alveolar mucosa, 
gingiva. floor of the mouth and lip are less commonly 
involved(4). These slow growing lesions are persistent, 
progressive, relentless and non reversible. As 
compared to other leukoplakias, which on an average 
have a 5% transformation rate to cancer, PVL has an 
almost 100% malignant transformation rate (2,5,6) 
 
 There is a preponderance of female patients in 
many studies (2,3,4,6) whereas other studies show 
equal sex distribution (7,8). The mean age of diagnosis 
of PVL ranges from 62 to 80 years. 
 
Etiopathogenesis 
 
 The exact etiologic agent of PVL is still not 
known. Patients usually have a history of minimal 
Fig. 8- Post operative  site following local excision of 
verrucous leukoplakic patch at later presentation. 
 
Fig. 6-Histopathology at later presentation - Deep keratin 
plugging. 
 
Fig. 7- Histopathology at later presentation - Proliferative 
epithelium with  bland appearance and tendency to form 
epithelial pearl. 
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tobacco exposure, 37% in a review of 137 patients by 
Cabay et al (4). The frequent absence of risk factors, a 
preponderance of women patients and occurrence at 
an older age suggests that the pathogenesis of 
carcinoma arising in PVL may be different from that of 
non PVL associated carcinoma. 
 
 An 89% positivity for HPV DNA using PCR in 
PVL was found by Palefsky(9). However, studies by 
Fettig et al(10) have shown that no HPV was detected 
in the ten gingival PVL cases that he studied. No 
evidence for a role of p53 gene mutations in the 
progression from PVL to oral squamous cell carcinoma 
could be found (11). Factors such as smoking, the 
presence of candida, immune deficiencies and Vitamin 
A therapy have no influence on the occurrence and 
progression of PVL(12)
 
.Studies by Bagan et al detected 
EBV in a higher percentage of patients with PVL when 
compared with Oral Squamous cell carcinoma without 
PVL although the role of EBV as an etiologic agent 
could not be proved.(13)
 
 
Histopathological features 
  
 PVL exhibits progressive histopathological 
features that may be observed in a single biopsy, 
multiple biopsies taken from a single patient at the 
same time or serial biopsies taken over time. If the 
lesions continue to grow horizontally and vertically, 
there are concurrent histopathological features of 
increasing hyperkeratosis with increased surface 
folding, verrucous papillomatosis, acanthosis and 
basilar hyperplasia with or without dysplasia. Only if 
these latter histopathological changes are observed 
and or there is a recurrence of a previously excised 
lesion could a white lesion be considered consistent 
with PVL clinically as stated by Cabay et al(4). 
 
 The precise classification of PVL in a staging 
continuum is problematic because sampling of the 
lesions occurs at uncontrolled intervals and because of 
the minimum cellular atypia often seen on biopsy. 
Hansen et al proposed a microscopic grading of PVL 
on a scale from 0-10 denoting a continuum of severity 
that included histologically normal oral mucosa, 
clinically homogenous leukoplakia, verrucous 
hyperplasia, verrucous carcinoma, papillary squamous 
cell carcinoma, less differentiated squamous cell 
carcinoma and intermediates(2). Batsakis et al 
suggested a histological staging of PVL that included 4 
phases (clinically flat leukoplakia without dysplasia, 
verrrucous hyperplasia, verrucous carcinoma and 
conventional squamous cell carcinoma with 
intermediates(3). 
 
 Since dysplasia is absent or is a late feature in 
many cases, it may lead to less aggressive treatment 
early in the disease process. Further there is an overlap 
between verrucous hyperplasia and verrucous 
carcinoma in histologic evaluation. For this reason, 
Murrah and Batsakis(14) suggest that biopsies should 
be taken from the margins of the lesions. 
 
 
Treatment 
 
 The treatment of PVL is still not satisfactory 
with high rates of recurrent disease, often within 
months of cessation of therapy. The  widespread 
disposition of the lesions in the oral cavity makes total 
excision impossible. Early and aggressive treatment of 
this lesion is recommended because of its relentless 
growth pattern and high malignant transformation 
rate. Surgery alone via scalpel/ laser excision or surgery 
in combination with methoisoprinol has been 
attempted(15). Non surgical approaches that have 
been considered are external beam radiation therapy, 
cyotherapy, topical Vitamin therapy with unsatisfactory 
results(3).Studies by Poveda-Roda R et al have shown 
that although topical/systemic retinoid therapy 
produced some improvement in one third of all 
patients with PVL, the efficacy and safety of these 
products need to be assessed especially since 33% of 
individuals worsen despite therapy and the frequent 
appearance of adverse effects.(16).Other strategies 
which may be considered in the future are anti HPV 
and antiTGF and pro-apoptotic trials. At present, poor 
outcome of therapy with a high rate of progression is 
reflective of under treatment and lack of effective 
therapies for PVL. 
 
 The main goal of therapy therefore, should be 
to administer sufficiently aggressive therapy consistent 
with clinical progression of the lesion in spite of the 
benign histologic findings. In addition, implementation 
of molecular markers of PVL which assess a high risk of 
progression to cancer will aid in the management of 
this lesion. 
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